|
VisiJet,
Inc. announced today that it has filed for FDA approval of its HydroKeratome device to be used in the popular LASIK
refractive surgery procedure. This device will replace the current metal blade
microkeratomes used to create a corneal flap prior to the use of the excimer
laser in this procedure performed by ophthalmologists.
It
is estimated that there will be over 800,000 refractive surgery procedures
performed in the United States alone this year. The growth rate of this
procedure has been approximately 100% per year for the past two years.
VisiJet's
Hydrokeratome uses a supersonic beam of water to make the corneal cuts instead
of a metal blade. The thickness of this waterjet beam is less than the size of a
human hair. This technology provides a cleaner, smoother cut than with the
current metal blades.
The
VisiJet HydroKeratome uses a disposable component that will be required for each
surgical procedure assuring sterility for every patient.
VisiJet
licenses the rights to nine issued patents and four patents pending in the
waterjet area including one specifically describing this device and its use as a
corneal cutting instrument.
VisiJet
and its associated company, SurgiJet, are developing a wide range of surgical
products using high pressure Waterjets for many medical applications.
Contact:
Victor Chapa - Phone (949) 380-4800, Ex.101
|
W H I T E
